Company: CSTL
Filing Date: 2025-11-03
Form Type: 10-Q
Source: 0001628280-25-048254
Chunk: 0

Company: CASTLE BIOSCIENCES INC
Filing Date: 2025-11-03
Form: 10-Q
Item: Item 1
Chunk 0
---
Item 1. Financial Statements.

CASTLE BIOSCIENCES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)

September 30, 2025December 31, 2024ASSETS(unaudited)Current Assets  Cash and cash equivalents$85,556 $119,709 Marketable investment securities201,986 173,421 Accounts receivable, net49,482 51,218 Inventory8,650 8,135 Prepaid expenses and other current assets11,895 7,671 Total current assets357,569 360,154 Long-term accounts receivable, net2,050 918 Property and equipment, net84,885 51,122 Operating lease assets15,151 11,584 Goodwill and other intangible assets, net101,849 106,229 Other assets – long-term1,282 1,228 Total assets$562,786 $531,235 LIABILITIES AND STOCKHOLDERS’ EQUITYCurrent LiabilitiesAccounts payable$12,211 $6,901 Accrued compensation31,763 32,555 Contingent consideration1,000 — Operating lease liabilities1,449 1,665 Current portion of long-term debt— 278 Other accrued and current liabilities8,885 7,993 Total current liabilities55,308 49,392 Long-term debt10,049 9,745 Noncurrent portion of contingent consideration1,500 — Noncurrent operating lease liabilities25,302 14,345 Noncurrent finance lease liabilities339 311 Deferred tax liability3,242 1,607 Total liabilities95,740 75,400 Commitments and Contingencies (Note 12)Stockholders’ EquityPreferred stock, $0.001 par value per share; 10,000,000 shares authorized as of September 30, 2025 and December 31, 2024; no shares issued and outstanding as of September 30, 2025 and December 31, 2024— — Common stock, $0.001 par value per share; 200,000,000 shares authorized as of September 30, 2025 and December 31, 2024; 29,161,863 and 28,483,195 shares issued and outstanding as of September 30